Assessment of Chromosome 8 Copy Number in Cervical Cancer by Fluorescent in situ Hybridization
- 30 June 1999
- journal article
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 66 (2), 157-162
- https://doi.org/10.1006/exmp.1999.2256
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Trisomy 8 in Embryonal Rhabdomyosarcoma Detected by Fluorescence In Situ HybridizationCancer Genetics and Cytogenetics, 1999
- Fluorescence In Situ Hybridization to Assess Aneuploidy for Chromosomes 7 and 8 in Hematologic DisordersCancer Genetics and Cytogenetics, 1998
- Fluorescence in situ hybridization assessment of chromosome 8 copy number in stage i and stage ii infiltrating ductal carcinoma of the breastCancer Genetics and Cytogenetics, 1997
- Stage I and Stage II Infiltrating Ductal Carcinoma of the Breast Analyzed for Chromosome 8 Copy Number Using Fluorescent in situ HybridizationPathobiology, 1997
- Fluorescentin situ hybridization assessment of chromosome 8 copy number in breast cancerBreast Cancer Research and Treatment, 1996
- Altered expression ofnm23-H1 and c-erbB-2 proteins have prognostic significance in adenocarcinoma but not in squamous cell carcinoma of the uterine cervixCancer, 1995
- Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization.Proceedings of the National Academy of Sciences, 1986